G. Cocco

Standardization of assay for cytokeratin-related tumor marker CYFRA21.1 in urine samples.

G. Capitanio, R. Dittadi, M. Gion, 1996, Clinical chemistry.

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation

S. Ascani, V. Conteduca, F. Sanguedolce, 2022, International journal of molecular sciences.

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression

S. Ascani, F. Sanguedolce, G. Carrieri, 2022, International journal of molecular sciences.

Primary Pulmonary B-Cell Lymphoma: A Review and Update

S. Ascani, C. Caprera, F. Sanguedolce, 2021, Cancers.

PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives

A. Fiorelli, S. Ascani, F. Sanguedolce, 2021, Minerva Respiratory Medicine.

From the Core to the Border of Locally Advanced Rectal Cancer: A Novel MRI-based Clinical-Radiomic Model Early Predicts Treatment Response

M. Caulo, P. Chiacchiaretta, D. Genovesi, 2020 .